Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
2020 · Scientific Reports · 55 citations
https://doi.org/10.1038/s41598-020-59711-y
S
Shuishu Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
3.5K
Citations
31
h-index
59
i10-index
Shuishu Wang is an academic researcher from National Institutes of Health. The author has contributed to research in topics: HIV Research and Treatment & Monoclonal and Polyclonal Antibodies Research & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 31, co-authored 86 publications.
ORCID: 0000-0002-0865-4522Papers by this author
worksIdentification and Structure of a Multidonor Class of Head-Directed Influenza-Neutralizing Antibodies Reveal the Mechanism for Its Recurrent Elicitation
2020 · Cell Reports · 29 citations
https://doi.org/10.1016/j.celrep.2020.108088
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
2020 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2020.107981
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques
2024 · Cell · 25 citations
https://doi.org/10.1016/j.cell.2024.10.003
Cryo-EM structures of prefusion SIV envelope trimer
2022 · Nature Structural & Molecular Biology · 20 citations
https://doi.org/10.1038/s41594-022-00852-1
Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
2021 · Cell Reports · 13 citations
https://doi.org/10.1016/j.celrep.2021.109922
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat